The DCS cohort is an on-going population-based cohort including almost all people with type 2 diabetes (T2D) in the catchment area of the DCS, a primary care setting in the West-Friesland area of the Netherlands. As part of routine diabetes care, participants receive a standardized annual assessment with measurement of diabetes-related risk factors and complications.
The resulting database included 13,955 people with T2D in 2017, with follow-up ranging from 1 to 19 years. The study has been approved by the Medical Ethical Review Committee of the VU University Medical Center, Amsterdam. Individuals were informed about the use of their data and were offered an opt-out. Data were used anonymously. A description of the DCS cohort has been published previously.
You can find more information on the Hoorn studies cohort website.
Meta-data of this cohort can be found on the website of GECCO.
APH contact persons: Petra Elders, Joline Beulens, Amber van der Heijden
Contact: p.elders@amsterdamumc.nl